Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/31857
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chow K.V. | en |
dc.contributor.author | Hogan C. | en |
dc.contributor.author | Nicholls K. | en |
dc.contributor.author | Branley P. | en |
dc.contributor.author | Carroll R. | en |
dc.contributor.author | Becker G. | en |
dc.date.accessioned | 2021-05-14T10:47:04Z | en |
dc.date.available | 2021-05-14T10:47:04Z | en |
dc.date.copyright | 2007 | en |
dc.date.created | 20070604 | en |
dc.date.issued | 2012-10-16 | en |
dc.identifier.citation | Internal Medicine Journal. 37 (5) (pp 329-332), 2007. Date of Publication: May 2007. | en |
dc.identifier.issn | 1444-0903 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/31857 | en |
dc.description.abstract | Thrombotic thrombocytopenic purpura is a rare condition characterized by microangiopathic haemolytic anaemia, thrombocytopenia, altered neurology, renal impairment and fever. While plasma exchange has reduced mortality from more than 90% to between 10 and 30%, a proportion of cases fail to respond. Rituximab may be efficacious in the management of refractory cases of thrombotic thrombocytopenic purpura. We present two cases in which rituximab was used with successful outcomes. Treatment resulted in resolution of severe clinical and haematological abnormalities in both patients. There has been no relapse after 16 months follow up. Our experience supports the use of rituximab in difficult cases of TTP. Ongoing evaluation of its use is in progress at our institution. © 2007 The Authors. | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | Blackwell Publishing (550 Swanston Street, Carlton South VIC 3053, Australia) | en |
dc.title | Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange. | en |
dc.type | Article | en |
dc.type.studyortrial | Case series or case report | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/j.1445-5994.2007.01338.x | en |
dc.publisher.place | Australia | en |
dc.identifier.pubmedid | 17504282 [http://www.ncbi.nlm.nih.gov/pubmed/?term=17504282] | en |
dc.identifier.source | 46744093 | en |
dc.identifier.institution | (Chow, Carroll, Nicholls, Becker) Department of Nephrology, Royal Melbourne Hospital, Melbourne, Vic., Australia (Hogan) Department of Haematology, Royal Melbourne Hospital, Melbourne, Vic., Australia (Branley) Monash Medical Centre, Royal Melbourne Hospital, Melbourne, Vic., Australia (Nicholls, Becker, Hogan) University of Melbourne, Melbourne, Vic., Australia (Nicholls) Department of Nephrology, Royal Melbourne Hospital, Grattan Street, Parkville, Vic. 3050, Australia | en |
dc.description.address | K. Nicholls, Department of Nephrology, Royal Melbourne Hospital, Grattan Street, Parkville, Vic. 3050, Australia. E-mail: kathy.nicholls@mh.org.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2012 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Anti-CD20 antibody Plasma exchange Rituximab Thrombotic thrombocytopenic purpura | en |
dc.identifier.authoremail | Nicholls K.; kathy.nicholls@mh.org.au | en |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.